About: MAPRx

Earlier today, the MAPRx Coalition submitted to the Centers for Medicare & Medicaid Services (CMS) comments regarding the implementation of the Medicare Drug Price Negotiation Program (MDPNP) for initial price applicability year 2026.

The Coalition appreciates the opportunity to comment on how Medicare intends to negotiate with
pharmaceutical manufacturers for lower...

The Annual Open Enrollment for Medicare prescription drug coverage (Part D) is October 15, 2022 – December 7, 2022 for coverage beginning January 1, 2023. Plans make changes to benefits and costs, and there are also new plans in many areas of the country. Changes to the Part D benefit as a whole...

A new report commissioned by the MAPRx Coalition examines the growing clinical evidence for coverage of anti-obesity medications (AOMs) approved by the Food and Drug Administration in Medicare Part D.

As the medical community’s understanding of disease states evolves, MAPRx is calling on the Part D program to evolve...

Earlier today, the MAPRx Coalition and 35 member organizations submitted a letter to Senate leadership ahead of their continued consideration of the Inflation Reduction Act of 2022 via the Senate's reconciliation process.

While members of the Coalition have differing views on other components of the expansive package, the Coalition and...

The Annual Open Enrollment for Medicare prescription drug coverage (Part D) is October 15, 2021 – December 7, 2021 for coverage beginning January 1, 2022. Plans make changes to benefits and costs, and there are also new plans in many areas of the country. Changes to the Part D benefit as a whole...

Earlier today, 29 members of the MAPRx Coalition sent a letter to Congressional leaders urging them to establish an out-of-pocket (OOP) cap for Medicare Part D to limit the amount Medicare beneficiaries have to pay for covered prescription drugs.

The Coalition continues to believe that the lack of an...

Earlier today, the MAPRx Coalition hosted a virtual briefing for members of Congress, their staff, and MAPRx member organizations.

After Corey Ford of Xcenda provided an overview of the Medicare Part D benefit, Illy Jaffer of the American Cancer Society Cancer Action Network and Bari Talente of the National...

Earlier today, the MAPRx Coalition and 27 of its member organizations submitted letters to House and Senate leadership in response to the ongoing congressional efforts to address drug pricing and affordability.

Specifically, the letters urged congressional leaders to focus on the...